Synapse

← Journal of Clinical Pharmacy and Therapeutics

Papers in Journal of Clinical Pharmacy and Therapeutics

Page 6 · newest first

  1. The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenationJournal of Clinical Pharmacy and Therapeutics · 2022
  2. Improving patient outcomes by promoting antimicrobial stewardship for patients with positive blood cultures: Investigation of patients with gram negative bacteriumJournal of Clinical Pharmacy and Therapeutics · 2022
  3. Clinical and laboratory responses to tigecycline in childrenJournal of Clinical Pharmacy and Therapeutics · 2022
  4. Safety and efficacy of sofosbuvir‐based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta‐analysisJournal of Clinical Pharmacy and Therapeutics · 2022
  5. A retrospective observational study of the treatment with polymyxin B for liver transplantation recipients infected by multidrug‐resistant gram‐negative bacteriaJournal of Clinical Pharmacy and Therapeutics · 2022
  6. Discoidin domain receptor 1 may be involved in biological barrier homeostasisJournal of Clinical Pharmacy and Therapeutics · 2022
  7. Effectiveness and safety of sacubitril/valsartan for patients with hypertension and heart failure in the real‐world setting: A retrospective study in ChinaJournal of Clinical Pharmacy and Therapeutics · 2022
  8. Does eltrombopag lead to thrombotic events? A pharmacovigilance study of theFDAadverse event reporting systemJournal of Clinical Pharmacy and Therapeutics · 2022
  9. Validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system for augmented renal clearance prediction in a trauma subgroup of a mixed ICU populationJournal of Clinical Pharmacy and Therapeutics · 2022
  10. Addition of roxadustat to erythropoiesis‐stimulating agent ( ESA ) effectively corrects ESA ‐hyporesponsive anaemia in patients on peritoneal dialysisJournal of Clinical Pharmacy and Therapeutics · 2022
  11. Rapid, simple, and economical LC–MS/MS method for simultaneous determination of ceftazidime and avibactam in human plasma and its application in therapeutic drug monitoringJournal of Clinical Pharmacy and Therapeutics · 2022
  12. Medications used in paediatric intensive care by continuous infusion: Do the technical aspects of the package inserts corroborate scientific evidence?Journal of Clinical Pharmacy and Therapeutics · 2022
  13. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim‐sulfamethoxazole without changes in glomerular filtration rateJournal of Clinical Pharmacy and Therapeutics · 2022
  14. Clinical development of anticancer drugs can be enhanced using efficacy data of small population clinical trialsJournal of Clinical Pharmacy and Therapeutics · 2022
  15. Pharmaceutical care education at pharmacy colleges in the Middle East and North Africa region: A systematic reviewJournal of Clinical Pharmacy and Therapeutics · 2022
  16. Rivaroxaban population pharmacokinetic and pharmacodynamic modeling in Iranian patientsJournal of Clinical Pharmacy and Therapeutics · 2022
  17. Pharmacokinetics, safety and efficacy of intra‐articular non‐steroidal anti‐inflammatory drug injections for the treatment of osteoarthritis: A narrative reviewJournal of Clinical Pharmacy and Therapeutics · 2022
  18. Impact of expedited programs in the United States, as foreign regulatory factors, on clinical development time in JapanJournal of Clinical Pharmacy and Therapeutics · 2022
  19. The effectiveness of esketamine and propofol versus dezocine and propofol sedation during gastroscopy: A randomized controlled studyJournal of Clinical Pharmacy and Therapeutics · 2022
  20. ABCB1 gene polymorphisms impact the effect of high‐dose intravenous methylprednisolone therapy on optic neuritis associated with AQP4‐IgG ‐positive neuromyelitis optica spectrum disorderJournal of Clinical Pharmacy and Therapeutics · 2022
  21. The role of the genetic variant FECH rs11660001 in the occurrence of anti‐tuberculosis drug‐induced liver injuryJournal of Clinical Pharmacy and Therapeutics · 2022
  22. Analysis of drug adverse events in elderly patients based on the Japanese Adverse Drug Event Report DatabaseJournal of Clinical Pharmacy and Therapeutics · 2022
  23. Clinical characteristics and treatment of terlipressin‐induced ischemic skin necrosis: A synthesis of 35 literature reported casesJournal of Clinical Pharmacy and Therapeutics · 2022
  24. Successful treatment of a case with synchronous follicular lymphoma and gastric adenocarcinoma with CD19 CAR T cells and literature reviewJournal of Clinical Pharmacy and Therapeutics · 2022
  25. High‐Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta‐Analysis of Randomized TrialsJournal of Clinical Pharmacy and Therapeutics · 2022
  26. Efficacy, safety and prognostic factors of camrelizumab plus carboplatin and pemetrexed chemotherapy in advanced lung adenocarcinoma patientsJournal of Clinical Pharmacy and Therapeutics · 2022
  27. Comparison of cold spray and shotblocker to reduce intramuscular injection pain: A randomized controlled trialJournal of Clinical Pharmacy and Therapeutics · 2022
  28. Characteristics of hospitals that report adverse drug reactions: Results of a nationwide survey in JapanJournal of Clinical Pharmacy and Therapeutics · 2022
  29. Real‐life contemporary vitamin K antagonist is still associated with very low time in therapeutic range despite strict international normalized ratio monitoring: Results of big data analysisJournal of Clinical Pharmacy and Therapeutics · 2022
  30. Pharmacokinetics of piperacillin and tazobactam in critically Ill patients treated with continuous kidney replacement therapy: A mini‐review and population pharmacokinetic analysisJournal of Clinical Pharmacy and Therapeutics · 2022
  31. Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchangeJournal of Clinical Pharmacy and Therapeutics · 2022
  32. Rapid clearance of tacrolimus blood concentration triggered by variant pharmacogenesJournal of Clinical Pharmacy and Therapeutics · 2022
  33. Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck serviceJournal of Clinical Pharmacy and Therapeutics · 2022
  34. A systematic review on the impact of pharmacist‐provided services on patients’ health outcomes in Arab countriesJournal of Clinical Pharmacy and Therapeutics · 2022
  35. Repositioning of Cannabis sativa : A topic under constructionJournal of Clinical Pharmacy and Therapeutics · 2022
  36. Liver failure caused by intravenous amiodarone and effective intervention measures: A case reportJournal of Clinical Pharmacy and Therapeutics · 2022
  37. Effects of linezolid on the haematological system in very low birth weight infants: A single‐centre retrospective studyJournal of Clinical Pharmacy and Therapeutics · 2022
  38. Incidence and risk factors for hyperkalaemia in patients treated for COVID‐19 with nafamostat mesylateJournal of Clinical Pharmacy and Therapeutics · 2022
  39. Implementation of a pharmacist‐led transitional pharmaceutical care programme: Process evaluation of Medication Actions to Reduce hospital admissions through a collaboration between Community and Hospital pharmacists (MARCH)Journal of Clinical Pharmacy and Therapeutics · 2022
  40. An open‐label, phase 1, randomized, three treatments, three‐period, crossover, relative bioavailability study of CC‐292, a potent and orally available inhibitor of bruton tyrosine kinaseJournal of Clinical Pharmacy and Therapeutics · 2022
  41. Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndromeJournal of Clinical Pharmacy and Therapeutics · 2022
  42. Four kinds of tocolytic therapy for preterm delivery: Systematic review and network meta‐analysisJournal of Clinical Pharmacy and Therapeutics · 2022
  43. Rapid infusion of fish oil‐based lipid emulsions: Is there a risk of fat overload syndrome? A case report of rapid administrationJournal of Clinical Pharmacy and Therapeutics · 2022
  44. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure–activity relationshipJournal of Clinical Pharmacy and Therapeutics · 2022
  45. Observation of clinical efficacy of the cefoperazone/sulbactam anti‐infective regimen in the treatment of multidrug‐resistant Acinetobacter baumannii lung infectionJournal of Clinical Pharmacy and Therapeutics · 2022
  46. Ceftolozane/tazobactam for difficult‐to‐treat Gram‐negative infections: A real‐world tertiary hospital experienceJournal of Clinical Pharmacy and Therapeutics · 2022
  47. Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co‐administration in patients with type 2 diabetes mellitusJournal of Clinical Pharmacy and Therapeutics · 2022
  48. ED 50 and ED 95 of propofol combined with different doses of esketamine for children undergoing upper gastrointestinal endoscopy: A prospective dose‐finding study using up‐and‐down sequential allocation methodJournal of Clinical Pharmacy and Therapeutics · 2022
  49. Oral immunosuppressants improve pregnancy outcomes in women with idiopathic recurrent miscarriage: A meta‐analysisJournal of Clinical Pharmacy and Therapeutics · 2022
  50. Network meta‐analysis on efficacy and safety of different Janus kinase inhibitors for ulcerative colitisJournal of Clinical Pharmacy and Therapeutics · 2022